Cannabis Prospect Articles
Facility Audits Provide Regulatory Structure
Publish Date: March 15, 2020 | Author: Theresa Espejo
With Canada legalizing adult access to both medical and recreational cannabis, its top-down approach brings with it a complex regulatory environment. One where decisions at the federal and provincial/territorial level, as well as municipalities, can be occurring simultaneously and sometimes inconsistently.
Legalization 2.0: IP and Regulatory Considerations for Edibles, Extracts and Topicals
Publish Date: October 1, 2019 | Author: Laurence MacPhie, Donald Bocchinfuso, Amanda Branch and Jennifer McKenzie
The legalization of cannabis edibles, extracts and topicals will expand the cannabis market and create new opportunities for producers, innovators and investors. According to a recent report from Deloitte, the Canadian market for these new cannabis products is expected to be worth $2.7 billion annually, with edibles accounting for more than half ($1.6 billion).
Artificial Intelligence, Learning and Explosive Growth in Cannabis
Publish Date: March 13, 2019 | Author: Rob Ayre, Communications Manager, Docebo Canada Inc.
Organizations operating in the industry have a distinct need for clear communication across multiple departments and sophisticated ways of training new employees quickly to ensure compliance, efficiency and more. Companies looking to grow and capitalize need to be agile and have the ability to train employees on the latest information necessary for success.
With high growth, comes high risk: Is the cannabis industry data protection ready?
Publish Date: November 12, 2018 | Author: Paul Saabas, Vice President, Shred-it
Many LPs operate clinics and dispensaries that collect personal and confidential medical information from patients. Cannabis players that chose to operate in the recreational space still collect personal information from customers and need to ensure that they hold themselves to the same standards as hospitals and medical clinics when it comes to information protection. A 2017 report from the Ponemon Institute states that healthcare organizations that had a data breach experienced a 6.25% decline in their stocks, lost more than 4% of patients and it took over three months to recover from the financial damages of the breach. It is expected that this same decline in stocks and customers can be seen in both the recreational and medicinal cannabis markets if a breach occurs.
Lessons from the U.S.: With Legalization Here Origin House Eyes Opportunities in Canadian Cannabis
Publish Date: October 31, 2018 | Author: Afzal Hasan
An interview with Afzal Hasan is the President and General Counsel of Origin House.